2,3,4,5,7,9,13,13A-OCTAHYDRO-8-METHOXY-7,9-DIOXO-2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXYLIC ACID LITHIUM SALT, (2R,5S,13AR)-
UNII 4QR9Z2D2KU

Substance Identification & Data

This profile provides standardized clinical and technical data for 2,3,4,5,7,9,13,13a-octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazepine-10-carboxylic Acid Lithium Salt, (2r,5s,13ar)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4QR9Z2D2KU.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2805335-05-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
4QR9Z2D2KU
CAS Registry Number
2805335-05-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
2,3,4,5,7,9,13,13A-OCTAHYDRO-8-METHOXY-7,9-DIOXO-2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXYLIC ACID LITHIUM SALT, (2R,5S,13AR)-
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C15H15N2O6.Li
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
XRWBNNQKTKUFPJ-GZJXKWBNSA-M
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
176507645
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O1[C@]2(N([C@]3(CC[C@@]1(C3)[H])[H])C(c4n(C2)cc(c(c4OC)=O)C(=O)[O-])=O)[H].[Li+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 2,3,4,5,7,9,13,13a-octahydro-8-methoxy-7,9-dioxo-2,5-methanopyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazepine-10-carboxylic Acid Lithium Salt, (2r,5s,13ar)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(2R,5S,13AR)-2,3,4,5,7,9,13,13A-OCTAHYDRO-8-METHOXY-7,9-DIOXO-2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXYLIC ACID LITHIUM SALT
2,3,4,5,7,9,13,13A-OCTAHYDRO-8-METHOXY-7,9-DIOXO-2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXYLIC ACID LITHIUM SALT, (2R,5S,13AR)-
2,5-METHANOPYRIDO(1',2':4,5)PYRAZINO(2,1-B)(1,3)OXAZEPINE-10-CARBOXYLIC ACID, 2,3,4,5,7,9,13,13A-OCTAHYDRO-8-METHOXY-7,9-DIOXO-, LITHIUM SALT (1:1), (2R,5S,13AR)-

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound